R Elaine Cagnina1, Melody G Duvall1,2, Julie Nijmeh1, Bruce D Levy1. 1. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital. 2. Division of Critical Care Medicine, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Abstract
PURPOSE OF REVIEW: Persistent unresolved inflammation results in a number of pathologic respiratory diseases including asthma, cystic fibrosis, acute respiratory distress syndrome (ARDS) and coronavirus disease 2019 (COVID-19)-associated ARDS. Inflammation resolution is an active series of biologic processes orchestrated by a family of bioactive specialized pro-resolving mediators (SPMs) derived from essential omega-3 and omega-6 polyunsaturated fatty acids (PUFAs). In this review, we highlight recent findings on dysregulated inflammation resolution in common respiratory diseases and recent literature on SPM generation with PUFA dietary supplementation with relevance to diseases of respiratory inflammation. RECENT FINDINGS: Human studies and preclinical models of diseases of lung inflammation have revealed disequilibrium in the levels of pro-inflammatory versus pro-resolving mediators. Recent studies identified actions for SPMs on regulating prophlogistic host responses and stimulating inflammation resolution pathways in inflammatory respiratory diseases. SUMMARY: Dietary marine oils are enriched in PUFAs and contain parent omega-3 and omega-6 fatty acids and precursors for conversion to SPMs. Nutritional supplementation with fish oils can boost SPM levels and offer a therapeutic approach targeting inflammation resolution pathways for diseases of lung inflammation.
PURPOSE OF REVIEW: Persistent unresolved inflammation results in a number of pathologic respiratory diseases including asthma, cystic fibrosis, acute respiratory distress syndrome (ARDS) and coronavirus disease 2019 (COVID-19)-associated ARDS. Inflammation resolution is an active series of biologic processes orchestrated by a family of bioactive specialized pro-resolving mediators (SPMs) derived from essential omega-3 and omega-6 polyunsaturated fatty acids (PUFAs). In this review, we highlight recent findings on dysregulated inflammation resolution in common respiratory diseases and recent literature on SPM generation with PUFA dietary supplementation with relevance to diseases of respiratory inflammation. RECENT FINDINGS: Human studies and preclinical models of diseases of lung inflammation have revealed disequilibrium in the levels of pro-inflammatory versus pro-resolving mediators. Recent studies identified actions for SPMs on regulating prophlogistic host responses and stimulating inflammation resolution pathways in inflammatory respiratory diseases. SUMMARY: Dietary marine oils are enriched in PUFAs and contain parent omega-3 and omega-6 fatty acids and precursors for conversion to SPMs. Nutritional supplementation with fish oils can boost SPM levels and offer a therapeutic approach targeting inflammation resolution pathways for diseases of lung inflammation.
Authors: Melody G Duvall; Cindy Barnig; Manuela Cernadas; Isabell Ricklefs; Nandini Krishnamoorthy; Nicole L Grossman; Nirav R Bhakta; John V Fahy; Eugene R Bleecker; Mario Castro; Serpil C Erzurum; Benjamin M Gaston; Nizar N Jarjour; David T Mauger; Sally E Wenzel; Suzy A Comhair; Andrea M Coverstone; Merritt L Fajt; Annette T Hastie; Mats W Johansson; Michael C Peters; Brenda R Phillips; Elliot Israel; Bruce D Levy Journal: Sci Immunol Date: 2017-03-10
Authors: Jun Yang; Jason P Eiserich; Carroll E Cross; Brian M Morrissey; Bruce D Hammock Journal: Free Radic Biol Med Date: 2012-05-08 Impact factor: 7.376
Authors: Patricia R Souza; Raquel M Marques; Esteban A Gomez; Romain A Colas; Roberta De Matteis; Anne Zak; Mital Patel; David J Collier; Jesmond Dalli Journal: Circ Res Date: 2019-12-12 Impact factor: 17.367
Authors: Thad W Vickery; Michael Armstrong; Jennifer M Kofonow; Charles E Robertson; Miranda E Kroehl; Nichole A Reisdorph; Vijay R Ramakrishnan; Daniel N Frank Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2020-11-26 Impact factor: 4.006
Authors: Michael J Yaeger; Sky W Reece; Brita Kilburg-Basnyat; Miles X Hodge; Anandita Pal; Katelyn Dunigan-Russell; Bin Luo; Dorothy J You; James C Bonner; Espen E Spangenburg; Debra Tokarz; Johanna Hannan; Michael Armstrong; Jonathan Manke; Nichole Reisdorph; Robert M Tighe; S Raza Shaikh; Kymberly M Gowdy Journal: Toxicol Sci Date: 2021-08-30 Impact factor: 4.109
Authors: Issa Beegun; Charlotte Camille Jouvene; Duco Steven Koenis; Gabriel Amador Aguirre; Patricia Regina Souza; Maria Gonzalez-Nunez; Lucy Ly; Kimberly Pistorius; Hemant M Kocher; William Ricketts; Gavin Thomas; Mauro Perretti; Ghassan Alusi; Paul Pfeffer; Jesmond Dalli Journal: Circ Res Date: 2021-07-09 Impact factor: 17.367